Adding insult to injury – Karen ’ s Story
I am 50 years old.
In July 2011 my GP found a large lump on my left ovary. While the NHS dragged out the endless tests my body got fed up of waiting! I didn’t even have a date for surgery when, in the early hours of September 20th I woke up in severe pain which rapidly worsened. I was at home alone at the time and called 999. They sent an ambulance immediately and kept me talking on the phone until it arrived about 10 minutes later. By the time I arrived I was lying on the floor with the phone near my ear as I was in so much pain I thought I was going to pass out. I was taken to A&E & from there to the gynae ...
Source: The Hysterectomy Association - March 12, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health breast cancer hysterectomy stories total abdominal hysterectomy Source Type: news
Adding insult to injury – Karen ’ s Story
I am 50 years old.
In July 2011 my GP found a large lump on my left ovary. While the NHS dragged out the endless tests my body got fed up of waiting! I didn’t even have a date for surgery when, in the early hours of September 20th I woke up in severe pain which rapidly worsened. I was at home alone at the time and called 999. They sent an ambulance immediately and kept me talking on the phone until it arrived about 10 minutes later. By the time I arrived I was lying on the floor with the phone near my ear as I was in so much pain I thought I was going to pass out. I was taken to A&E & from there to the gynae ...
Source: The Hysterectomy Association - March 12, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health breast cancer hysterectomy stories total abdominal hysterectomy Source Type: news
NICE issues ACD on bevacizumab for recurrent advanced platinum sensitive or partially platinum sensitive ovarian, fallopian tube, and primary peritoneal cancer
Source: NICE
Area: News
The National Institute for Health and Clinical Excellence (NICE) has issued for consultation an Appraisal Consultation Document (ACD) on the use of bevacizumab for treating advanced ovarian cancer that has returned six months or more after initial treatment with platinum-based chemotherapy (platinum-sensitive disease).
The following preliminary recommendations have been made:
. Bevacizumab in combination with gemcitabine and carboplatin is not recommended for treating the first recurrence of platinum-sensitive advanced ovarian cancer (including fallopian tube and primary ...
Source: NeLM - News - February 1, 2013 Category: Drugs & Pharmacology Source Type: news
